Global Functional Dyspepsia Drug Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Functional Dyspepsia Drug market size is predicted to grow from US$ 6147 million in 2025 to US$ 7300 million in 2031; it is expected to grow at a CAGR of 2.9% from 2025 to 2031.
Functional dyspepsia, also known as non-ulcer dyspepsia or indigestion, is a term used to describe a group of symptoms affecting the gastrointestinal tract, including stomach pain or discomfort, nausea, bloating and belching. The condition is diagnosed when no obvious cause can be found for the symptoms present, though a small percentage of cases are caused by infection with the germ Helicobacter pylori.
North America is the largest consumer of Functional Dyspepsia Drug in global market, with a consumption market share of 38.71% in 2019. Market is not concentrated.
LP Information, Inc. (LPI) ' newest research report, the “Functional Dyspepsia Drug Industry Forecast” looks at past sales and reviews total world Functional Dyspepsia Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Functional Dyspepsia Drug sales for 2025 through 2031. With Functional Dyspepsia Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Functional Dyspepsia Drug industry.
This Insight Report provides a comprehensive analysis of the global Functional Dyspepsia Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Functional Dyspepsia Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Functional Dyspepsia Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Functional Dyspepsia Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Functional Dyspepsia Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Functional Dyspepsia Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Functional Dyspepsia Drug market?
What factors are driving Functional Dyspepsia Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Functional Dyspepsia Drug market opportunities vary by end market size?
How does Functional Dyspepsia Drug break out by Type, by Application?
The global Functional Dyspepsia Drug market size is predicted to grow from US$ 6147 million in 2025 to US$ 7300 million in 2031; it is expected to grow at a CAGR of 2.9% from 2025 to 2031.
Functional dyspepsia, also known as non-ulcer dyspepsia or indigestion, is a term used to describe a group of symptoms affecting the gastrointestinal tract, including stomach pain or discomfort, nausea, bloating and belching. The condition is diagnosed when no obvious cause can be found for the symptoms present, though a small percentage of cases are caused by infection with the germ Helicobacter pylori.
North America is the largest consumer of Functional Dyspepsia Drug in global market, with a consumption market share of 38.71% in 2019. Market is not concentrated.
LP Information, Inc. (LPI) ' newest research report, the “Functional Dyspepsia Drug Industry Forecast” looks at past sales and reviews total world Functional Dyspepsia Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Functional Dyspepsia Drug sales for 2025 through 2031. With Functional Dyspepsia Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Functional Dyspepsia Drug industry.
This Insight Report provides a comprehensive analysis of the global Functional Dyspepsia Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Functional Dyspepsia Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Functional Dyspepsia Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Functional Dyspepsia Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Functional Dyspepsia Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Functional Dyspepsia Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Prokinetic Drugs
- Gastric Antisecretory Drugs
- Others
- Hospitals
- Drugstores
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bayer
- Sumitomo
- Cadila Pharmaceuticals
- Teva
- Johnson & Johnson
- Pfizer
- Sanofi
- AstraZeneca
- Jiangsu Aosaikang Pharma
- Eisai
- Kyowa Kirin Pharmaceuticals
- Hanmi Pharm
What is the 10-year outlook for the global Functional Dyspepsia Drug market?
What factors are driving Functional Dyspepsia Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Functional Dyspepsia Drug market opportunities vary by end market size?
How does Functional Dyspepsia Drug break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Functional Dyspepsia Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Functional Dyspepsia Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Functional Dyspepsia Drug by Country/Region, 2020, 2024 & 2031
2.2 Functional Dyspepsia Drug Segment by Type
2.2.1 Prokinetic Drugs
2.2.2 Gastric Antisecretory Drugs
2.2.3 Others
2.3 Functional Dyspepsia Drug Sales by Type
2.3.1 Global Functional Dyspepsia Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Functional Dyspepsia Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Functional Dyspepsia Drug Sale Price by Type (2020-2025)
2.4 Functional Dyspepsia Drug Segment by Application
2.4.1 Hospitals
2.4.2 Drugstores
2.5 Functional Dyspepsia Drug Sales by Application
2.5.1 Global Functional Dyspepsia Drug Sale Market Share by Application (2020-2025)
2.5.2 Global Functional Dyspepsia Drug Revenue and Market Share by Application (2020-2025)
2.5.3 Global Functional Dyspepsia Drug Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Functional Dyspepsia Drug Breakdown Data by Company
3.1.1 Global Functional Dyspepsia Drug Annual Sales by Company (2020-2025)
3.1.2 Global Functional Dyspepsia Drug Sales Market Share by Company (2020-2025)
3.2 Global Functional Dyspepsia Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Functional Dyspepsia Drug Revenue by Company (2020-2025)
3.2.2 Global Functional Dyspepsia Drug Revenue Market Share by Company (2020-2025)
3.3 Global Functional Dyspepsia Drug Sale Price by Company
3.4 Key Manufacturers Functional Dyspepsia Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Functional Dyspepsia Drug Product Location Distribution
3.4.2 Players Functional Dyspepsia Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FUNCTIONAL DYSPEPSIA DRUG BY GEOGRAPHIC REGION
4.1 World Historic Functional Dyspepsia Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Functional Dyspepsia Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Functional Dyspepsia Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Functional Dyspepsia Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Functional Dyspepsia Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Functional Dyspepsia Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Functional Dyspepsia Drug Sales Growth
4.4 APAC Functional Dyspepsia Drug Sales Growth
4.5 Europe Functional Dyspepsia Drug Sales Growth
4.6 Middle East & Africa Functional Dyspepsia Drug Sales Growth
5 AMERICAS
5.1 Americas Functional Dyspepsia Drug Sales by Country
5.1.1 Americas Functional Dyspepsia Drug Sales by Country (2020-2025)
5.1.2 Americas Functional Dyspepsia Drug Revenue by Country (2020-2025)
5.2 Americas Functional Dyspepsia Drug Sales by Type (2020-2025)
5.3 Americas Functional Dyspepsia Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Functional Dyspepsia Drug Sales by Region
6.1.1 APAC Functional Dyspepsia Drug Sales by Region (2020-2025)
6.1.2 APAC Functional Dyspepsia Drug Revenue by Region (2020-2025)
6.2 APAC Functional Dyspepsia Drug Sales by Type (2020-2025)
6.3 APAC Functional Dyspepsia Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Functional Dyspepsia Drug by Country
7.1.1 Europe Functional Dyspepsia Drug Sales by Country (2020-2025)
7.1.2 Europe Functional Dyspepsia Drug Revenue by Country (2020-2025)
7.2 Europe Functional Dyspepsia Drug Sales by Type (2020-2025)
7.3 Europe Functional Dyspepsia Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Functional Dyspepsia Drug by Country
8.1.1 Middle East & Africa Functional Dyspepsia Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Functional Dyspepsia Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Functional Dyspepsia Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Functional Dyspepsia Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Functional Dyspepsia Drug
10.3 Manufacturing Process Analysis of Functional Dyspepsia Drug
10.4 Industry Chain Structure of Functional Dyspepsia Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Functional Dyspepsia Drug Distributors
11.3 Functional Dyspepsia Drug Customer
12 WORLD FORECAST REVIEW FOR FUNCTIONAL DYSPEPSIA DRUG BY GEOGRAPHIC REGION
12.1 Global Functional Dyspepsia Drug Market Size Forecast by Region
12.1.1 Global Functional Dyspepsia Drug Forecast by Region (2026-2031)
12.1.2 Global Functional Dyspepsia Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Functional Dyspepsia Drug Forecast by Type (2026-2031)
12.7 Global Functional Dyspepsia Drug Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Bayer
13.1.1 Bayer Company Information
13.1.2 Bayer Functional Dyspepsia Drug Product Portfolios and Specifications
13.1.3 Bayer Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Bayer Main Business Overview
13.1.5 Bayer Latest Developments
13.2 Sumitomo
13.2.1 Sumitomo Company Information
13.2.2 Sumitomo Functional Dyspepsia Drug Product Portfolios and Specifications
13.2.3 Sumitomo Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Sumitomo Main Business Overview
13.2.5 Sumitomo Latest Developments
13.3 Cadila Pharmaceuticals
13.3.1 Cadila Pharmaceuticals Company Information
13.3.2 Cadila Pharmaceuticals Functional Dyspepsia Drug Product Portfolios and Specifications
13.3.3 Cadila Pharmaceuticals Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Cadila Pharmaceuticals Main Business Overview
13.3.5 Cadila Pharmaceuticals Latest Developments
13.4 Teva
13.4.1 Teva Company Information
13.4.2 Teva Functional Dyspepsia Drug Product Portfolios and Specifications
13.4.3 Teva Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Teva Main Business Overview
13.4.5 Teva Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Functional Dyspepsia Drug Product Portfolios and Specifications
13.5.3 Johnson & Johnson Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Functional Dyspepsia Drug Product Portfolios and Specifications
13.6.3 Pfizer Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Sanofi
13.7.1 Sanofi Company Information
13.7.2 Sanofi Functional Dyspepsia Drug Product Portfolios and Specifications
13.7.3 Sanofi Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Sanofi Main Business Overview
13.7.5 Sanofi Latest Developments
13.8 AstraZeneca
13.8.1 AstraZeneca Company Information
13.8.2 AstraZeneca Functional Dyspepsia Drug Product Portfolios and Specifications
13.8.3 AstraZeneca Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 AstraZeneca Main Business Overview
13.8.5 AstraZeneca Latest Developments
13.9 Jiangsu Aosaikang Pharma
13.9.1 Jiangsu Aosaikang Pharma Company Information
13.9.2 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Product Portfolios and Specifications
13.9.3 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Jiangsu Aosaikang Pharma Main Business Overview
13.9.5 Jiangsu Aosaikang Pharma Latest Developments
13.10 Eisai
13.10.1 Eisai Company Information
13.10.2 Eisai Functional Dyspepsia Drug Product Portfolios and Specifications
13.10.3 Eisai Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Eisai Main Business Overview
13.10.5 Eisai Latest Developments
13.11 Kyowa Kirin Pharmaceuticals
13.11.1 Kyowa Kirin Pharmaceuticals Company Information
13.11.2 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Product Portfolios and Specifications
13.11.3 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Kyowa Kirin Pharmaceuticals Main Business Overview
13.11.5 Kyowa Kirin Pharmaceuticals Latest Developments
13.12 Hanmi Pharm
13.12.1 Hanmi Pharm Company Information
13.12.2 Hanmi Pharm Functional Dyspepsia Drug Product Portfolios and Specifications
13.12.3 Hanmi Pharm Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Hanmi Pharm Main Business Overview
13.12.5 Hanmi Pharm Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1.Functional Dyspepsia Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2.Functional Dyspepsia Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Prokinetic Drugs
Table 4. Major Players of Gastric Antisecretory Drugs
Table 5. Major Players of Others
Table 6. GlobalFunctional Dyspepsia Drug Sales byType (2020-2025) & (M Units)
Table 7. GlobalFunctional Dyspepsia Drug Sales Market Share byType (2020-2025)
Table 8. GlobalFunctional Dyspepsia Drug Revenue byType (2020-2025) & ($ million)
Table 9. GlobalFunctional Dyspepsia Drug Revenue Market Share byType (2020-2025)
Table 10. GlobalFunctional Dyspepsia Drug Sale Price byType (2020-2025) & (US$/Unit)
Table 11. GlobalFunctional Dyspepsia Drug Sale by Application (2020-2025) & (M Units)
Table 12. GlobalFunctional Dyspepsia Drug Sale Market Share by Application (2020-2025)
Table 13. GlobalFunctional Dyspepsia Drug Revenue by Application (2020-2025) & ($ million)
Table 14. GlobalFunctional Dyspepsia Drug Revenue Market Share by Application (2020-2025)
Table 15. GlobalFunctional Dyspepsia Drug Sale Price by Application (2020-2025) & (US$/Unit)
Table 16. GlobalFunctional Dyspepsia Drug Sales by Company (2020-2025) & (M Units)
Table 17. GlobalFunctional Dyspepsia Drug Sales Market Share by Company (2020-2025)
Table 18. GlobalFunctional Dyspepsia Drug Revenue by Company (2020-2025) & ($ millions)
Table 19. GlobalFunctional Dyspepsia Drug Revenue Market Share by Company (2020-2025)
Table 20. GlobalFunctional Dyspepsia Drug Sale Price by Company (2020-2025) & (US$/Unit)
Table 21. Key ManufacturersFunctional Dyspepsia Drug Producing Area Distribution and Sales Area
Table 22. PlayersFunctional Dyspepsia Drug Products Offered
Table 23.Functional Dyspepsia Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. GlobalFunctional Dyspepsia Drug Sales by Geographic Region (2020-2025) & (M Units)
Table 27. GlobalFunctional Dyspepsia Drug Sales Market Share Geographic Region (2020-2025)
Table 28. GlobalFunctional Dyspepsia Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. GlobalFunctional Dyspepsia Drug Revenue Market Share by Geographic Region (2020-2025)
Table 30. GlobalFunctional Dyspepsia Drug Sales by Country/Region (2020-2025) & (M Units)
Table 31. GlobalFunctional Dyspepsia Drug Sales Market Share by Country/Region (2020-2025)
Table 32. GlobalFunctional Dyspepsia Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. GlobalFunctional Dyspepsia Drug Revenue Market Share by Country/Region (2020-2025)
Table 34. AmericasFunctional Dyspepsia Drug Sales by Country (2020-2025) & (M Units)
Table 35. AmericasFunctional Dyspepsia Drug Sales Market Share by Country (2020-2025)
Table 36. AmericasFunctional Dyspepsia Drug Revenue by Country (2020-2025) & ($ millions)
Table 37. AmericasFunctional Dyspepsia Drug Sales byType (2020-2025) & (M Units)
Table 38. AmericasFunctional Dyspepsia Drug Sales by Application (2020-2025) & (M Units)
Table 39. APACFunctional Dyspepsia Drug Sales by Region (2020-2025) & (M Units)
Table 40. APACFunctional Dyspepsia Drug Sales Market Share by Region (2020-2025)
Table 41. APACFunctional Dyspepsia Drug Revenue by Region (2020-2025) & ($ millions)
Table 42. APACFunctional Dyspepsia Drug Sales byType (2020-2025) & (M Units)
Table 43. APACFunctional Dyspepsia Drug Sales by Application (2020-2025) & (M Units)
Table 44. EuropeFunctional Dyspepsia Drug Sales by Country (2020-2025) & (M Units)
Table 45. EuropeFunctional Dyspepsia Drug Revenue by Country (2020-2025) & ($ millions)
Table 46. EuropeFunctional Dyspepsia Drug Sales byType (2020-2025) & (M Units)
Table 47. EuropeFunctional Dyspepsia Drug Sales by Application (2020-2025) & (M Units)
Table 48. Middle East & AfricaFunctional Dyspepsia Drug Sales by Country (2020-2025) & (M Units)
Table 49. Middle East & AfricaFunctional Dyspepsia Drug Revenue Market Share by Country (2020-2025)
Table 50. Middle East & AfricaFunctional Dyspepsia Drug Sales byType (2020-2025) & (M Units)
Table 51. Middle East & AfricaFunctional Dyspepsia Drug Sales by Application (2020-2025) & (M Units)
Table 52. Key Market Drivers & Growth Opportunities ofFunctional Dyspepsia Drug
Table 53. Key Market Challenges & Risks ofFunctional Dyspepsia Drug
Table 54. Key IndustryTrends ofFunctional Dyspepsia Drug
Table 55.Functional Dyspepsia Drug Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57.Functional Dyspepsia Drug Distributors List
Table 58.Functional Dyspepsia Drug Customer List
Table 59. GlobalFunctional Dyspepsia Drug SalesForecast by Region (2026-2031) & (M Units)
Table 60. GlobalFunctional Dyspepsia Drug RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. AmericasFunctional Dyspepsia Drug SalesForecast by Country (2026-2031) & (M Units)
Table 62. AmericasFunctional Dyspepsia Drug Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APACFunctional Dyspepsia Drug SalesForecast by Region (2026-2031) & (M Units)
Table 64. APACFunctional Dyspepsia Drug Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. EuropeFunctional Dyspepsia Drug SalesForecast by Country (2026-2031) & (M Units)
Table 66. EuropeFunctional Dyspepsia Drug RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & AfricaFunctional Dyspepsia Drug SalesForecast by Country (2026-2031) & (M Units)
Table 68. Middle East & AfricaFunctional Dyspepsia Drug RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. GlobalFunctional Dyspepsia Drug SalesForecast byType (2026-2031) & (M Units)
Table 70. GlobalFunctional Dyspepsia Drug RevenueForecast byType (2026-2031) & ($ millions)
Table 71. GlobalFunctional Dyspepsia Drug SalesForecast by Application (2026-2031) & (M Units)
Table 72. GlobalFunctional Dyspepsia Drug RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Bayer Basic Information,Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 74. BayerFunctional Dyspepsia Drug Product Portfolios and Specifications
Table 75. BayerFunctional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 76. Bayer Main Business
Table 77. Bayer Latest Developments
Table 78. Sumitomo Basic Information,Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 79. SumitomoFunctional Dyspepsia Drug Product Portfolios and Specifications
Table 80. SumitomoFunctional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Sumitomo Main Business
Table 82. Sumitomo Latest Developments
Table 83. Cadila Pharmaceuticals Basic Information,Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 84. Cadila PharmaceuticalsFunctional Dyspepsia Drug Product Portfolios and Specifications
Table 85. Cadila PharmaceuticalsFunctional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 86. Cadila Pharmaceuticals Main Business
Table 87. Cadila Pharmaceuticals Latest Developments
Table 88.Teva Basic Information,Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 89.TevaFunctional Dyspepsia Drug Product Portfolios and Specifications
Table 90.TevaFunctional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 91.Teva Main Business
Table 92.Teva Latest Developments
Table 93. Johnson & Johnson Basic Information,Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. Johnson & JohnsonFunctional Dyspepsia Drug Product Portfolios and Specifications
Table 95. Johnson & JohnsonFunctional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. Johnson & Johnson Main Business
Table 97. Johnson & Johnson Latest Developments
Table 98. Pfizer Basic Information,Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. PfizerFunctional Dyspepsia Drug Product Portfolios and Specifications
Table 100. PfizerFunctional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 101. Pfizer Main Business
Table 102. Pfizer Latest Developments
Table 103. Sanofi Basic Information,Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. SanofiFunctional Dyspepsia Drug Product Portfolios and Specifications
Table 105. SanofiFunctional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 106. Sanofi Main Business
Table 107. Sanofi Latest Developments
Table 108. AstraZeneca Basic Information,Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. AstraZenecaFunctional Dyspepsia Drug Product Portfolios and Specifications
Table 110. AstraZenecaFunctional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 111. AstraZeneca Main Business
Table 112. AstraZeneca Latest Developments
Table 113. Jiangsu Aosaikang Pharma Basic Information,Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 114. Jiangsu Aosaikang PharmaFunctional Dyspepsia Drug Product Portfolios and Specifications
Table 115. Jiangsu Aosaikang PharmaFunctional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 116. Jiangsu Aosaikang Pharma Main Business
Table 117. Jiangsu Aosaikang Pharma Latest Developments
Table 118. Eisai Basic Information,Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 119. EisaiFunctional Dyspepsia Drug Product Portfolios and Specifications
Table 120. EisaiFunctional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 121. Eisai Main Business
Table 122. Eisai Latest Developments
Table 123. Kyowa Kirin Pharmaceuticals Basic Information,Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 124. Kyowa Kirin PharmaceuticalsFunctional Dyspepsia Drug Product Portfolios and Specifications
Table 125. Kyowa Kirin PharmaceuticalsFunctional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 126. Kyowa Kirin Pharmaceuticals Main Business
Table 127. Kyowa Kirin Pharmaceuticals Latest Developments
Table 128. Hanmi Pharm Basic Information,Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 129. Hanmi PharmFunctional Dyspepsia Drug Product Portfolios and Specifications
Table 130. Hanmi PharmFunctional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 131. Hanmi Pharm Main Business
Table 132. Hanmi Pharm Latest Developments
LIST OFFIGURES
Figure 1. Picture ofFunctional Dyspepsia Drug
Figure 2.Functional Dyspepsia Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. GlobalFunctional Dyspepsia Drug Sales Growth Rate 2020-2031 (M Units)
Figure 7. GlobalFunctional Dyspepsia Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8.Functional Dyspepsia Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9.Functional Dyspepsia Drug Sales Market Share by Country/Region (2024)
Figure 10.Functional Dyspepsia Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Prokinetic Drugs
Figure 12. Product Picture of Gastric Antisecretory Drugs
Figure 13. Product Picture of Others
Figure 14. GlobalFunctional Dyspepsia Drug Sales Market Share byType in 2025
Figure 15. GlobalFunctional Dyspepsia Drug Revenue Market Share byType (2020-2025)
Figure 16.Functional Dyspepsia Drug Consumed in Hospitals
Figure 17. GlobalFunctional Dyspepsia Drug Market: Hospitals (2020-2025) & (M Units)
Figure 18.Functional Dyspepsia Drug Consumed in Drugstores
Figure 19. GlobalFunctional Dyspepsia Drug Market: Drugstores (2020-2025) & (M Units)
Figure 20. GlobalFunctional Dyspepsia Drug Sale Market Share by Application (2024)
Figure 21. GlobalFunctional Dyspepsia Drug Revenue Market Share by Application in 2025
Figure 22.Functional Dyspepsia Drug Sales by Company in 2025 (M Units)
Figure 23. GlobalFunctional Dyspepsia Drug Sales Market Share by Company in 2025
Figure 24.Functional Dyspepsia Drug Revenue by Company in 2025 ($ millions)
Figure 25. GlobalFunctional Dyspepsia Drug Revenue Market Share by Company in 2025
Figure 26. GlobalFunctional Dyspepsia Drug Sales Market Share by Geographic Region (2020-2025)
Figure 27. GlobalFunctional Dyspepsia Drug Revenue Market Share by Geographic Region in 2025
Figure 28. AmericasFunctional Dyspepsia Drug Sales 2020-2025 (M Units)
Figure 29. AmericasFunctional Dyspepsia Drug Revenue 2020-2025 ($ millions)
Figure 30. APACFunctional Dyspepsia Drug Sales 2020-2025 (M Units)
Figure 31. APACFunctional Dyspepsia Drug Revenue 2020-2025 ($ millions)
Figure 32. EuropeFunctional Dyspepsia Drug Sales 2020-2025 (M Units)
Figure 33. EuropeFunctional Dyspepsia Drug Revenue 2020-2025 ($ millions)
Figure 34. Middle East & AfricaFunctional Dyspepsia Drug Sales 2020-2025 (M Units)
Figure 35. Middle East & AfricaFunctional Dyspepsia Drug Revenue 2020-2025 ($ millions)
Figure 36. AmericasFunctional Dyspepsia Drug Sales Market Share by Country in 2025
Figure 37. AmericasFunctional Dyspepsia Drug Revenue Market Share by Country (2020-2025)
Figure 38. AmericasFunctional Dyspepsia Drug Sales Market Share byType (2020-2025)
Figure 39. AmericasFunctional Dyspepsia Drug Sales Market Share by Application (2020-2025)
Figure 40. United StatesFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 41. CanadaFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 42. MexicoFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 43. BrazilFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 44. APACFunctional Dyspepsia Drug Sales Market Share by Region in 2025
Figure 45. APACFunctional Dyspepsia Drug Revenue Market Share by Region (2020-2025)
Figure 46. APACFunctional Dyspepsia Drug Sales Market Share byType (2020-2025)
Figure 47. APACFunctional Dyspepsia Drug Sales Market Share by Application (2020-2025)
Figure 48. ChinaFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 49. JapanFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 50. South KoreaFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 51. Southeast AsiaFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 52. IndiaFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 53. AustraliaFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 54. ChinaTaiwanFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. EuropeFunctional Dyspepsia Drug Sales Market Share by Country in 2025
Figure 56. EuropeFunctional Dyspepsia Drug Revenue Market Share by Country (2020-2025)
Figure 57. EuropeFunctional Dyspepsia Drug Sales Market Share byType (2020-2025)
Figure 58. EuropeFunctional Dyspepsia Drug Sales Market Share by Application (2020-2025)
Figure 59. GermanyFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 60.FranceFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 61. UKFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 62. ItalyFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 63. RussiaFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 64. Middle East & AfricaFunctional Dyspepsia Drug Sales Market Share by Country (2020-2025)
Figure 65. Middle East & AfricaFunctional Dyspepsia Drug Sales Market Share byType (2020-2025)
Figure 66. Middle East & AfricaFunctional Dyspepsia Drug Sales Market Share by Application (2020-2025)
Figure 67. EgyptFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 68. South AfricaFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 69. IsraelFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 70.TurkeyFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 71. GCC CountriesFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis ofFunctional Dyspepsia Drug in 2025
Figure 73. Manufacturing Process Analysis ofFunctional Dyspepsia Drug
Figure 74. Industry Chain Structure ofFunctional Dyspepsia Drug
Figure 75. Channels of Distribution
Figure 76. GlobalFunctional Dyspepsia Drug Sales MarketForecast by Region (2026-2031)
Figure 77. GlobalFunctional Dyspepsia Drug Revenue Market ShareForecast by Region (2026-2031)
Figure 78. GlobalFunctional Dyspepsia Drug Sales Market ShareForecast byType (2026-2031)
Figure 79. GlobalFunctional Dyspepsia Drug Revenue Market ShareForecast byType (2026-2031)
Figure 80. GlobalFunctional Dyspepsia Drug Sales Market ShareForecast by Application (2026-2031)
Figure 81. GlobalFunctional Dyspepsia Drug Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Functional Dyspepsia Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Functional Dyspepsia Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Functional Dyspepsia Drug by Country/Region, 2020, 2024 & 2031
2.2 Functional Dyspepsia Drug Segment by Type
2.2.1 Prokinetic Drugs
2.2.2 Gastric Antisecretory Drugs
2.2.3 Others
2.3 Functional Dyspepsia Drug Sales by Type
2.3.1 Global Functional Dyspepsia Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Functional Dyspepsia Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Functional Dyspepsia Drug Sale Price by Type (2020-2025)
2.4 Functional Dyspepsia Drug Segment by Application
2.4.1 Hospitals
2.4.2 Drugstores
2.5 Functional Dyspepsia Drug Sales by Application
2.5.1 Global Functional Dyspepsia Drug Sale Market Share by Application (2020-2025)
2.5.2 Global Functional Dyspepsia Drug Revenue and Market Share by Application (2020-2025)
2.5.3 Global Functional Dyspepsia Drug Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Functional Dyspepsia Drug Breakdown Data by Company
3.1.1 Global Functional Dyspepsia Drug Annual Sales by Company (2020-2025)
3.1.2 Global Functional Dyspepsia Drug Sales Market Share by Company (2020-2025)
3.2 Global Functional Dyspepsia Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Functional Dyspepsia Drug Revenue by Company (2020-2025)
3.2.2 Global Functional Dyspepsia Drug Revenue Market Share by Company (2020-2025)
3.3 Global Functional Dyspepsia Drug Sale Price by Company
3.4 Key Manufacturers Functional Dyspepsia Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Functional Dyspepsia Drug Product Location Distribution
3.4.2 Players Functional Dyspepsia Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FUNCTIONAL DYSPEPSIA DRUG BY GEOGRAPHIC REGION
4.1 World Historic Functional Dyspepsia Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Functional Dyspepsia Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Functional Dyspepsia Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Functional Dyspepsia Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Functional Dyspepsia Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Functional Dyspepsia Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Functional Dyspepsia Drug Sales Growth
4.4 APAC Functional Dyspepsia Drug Sales Growth
4.5 Europe Functional Dyspepsia Drug Sales Growth
4.6 Middle East & Africa Functional Dyspepsia Drug Sales Growth
5 AMERICAS
5.1 Americas Functional Dyspepsia Drug Sales by Country
5.1.1 Americas Functional Dyspepsia Drug Sales by Country (2020-2025)
5.1.2 Americas Functional Dyspepsia Drug Revenue by Country (2020-2025)
5.2 Americas Functional Dyspepsia Drug Sales by Type (2020-2025)
5.3 Americas Functional Dyspepsia Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Functional Dyspepsia Drug Sales by Region
6.1.1 APAC Functional Dyspepsia Drug Sales by Region (2020-2025)
6.1.2 APAC Functional Dyspepsia Drug Revenue by Region (2020-2025)
6.2 APAC Functional Dyspepsia Drug Sales by Type (2020-2025)
6.3 APAC Functional Dyspepsia Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Functional Dyspepsia Drug by Country
7.1.1 Europe Functional Dyspepsia Drug Sales by Country (2020-2025)
7.1.2 Europe Functional Dyspepsia Drug Revenue by Country (2020-2025)
7.2 Europe Functional Dyspepsia Drug Sales by Type (2020-2025)
7.3 Europe Functional Dyspepsia Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Functional Dyspepsia Drug by Country
8.1.1 Middle East & Africa Functional Dyspepsia Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Functional Dyspepsia Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Functional Dyspepsia Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Functional Dyspepsia Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Functional Dyspepsia Drug
10.3 Manufacturing Process Analysis of Functional Dyspepsia Drug
10.4 Industry Chain Structure of Functional Dyspepsia Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Functional Dyspepsia Drug Distributors
11.3 Functional Dyspepsia Drug Customer
12 WORLD FORECAST REVIEW FOR FUNCTIONAL DYSPEPSIA DRUG BY GEOGRAPHIC REGION
12.1 Global Functional Dyspepsia Drug Market Size Forecast by Region
12.1.1 Global Functional Dyspepsia Drug Forecast by Region (2026-2031)
12.1.2 Global Functional Dyspepsia Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Functional Dyspepsia Drug Forecast by Type (2026-2031)
12.7 Global Functional Dyspepsia Drug Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Bayer
13.1.1 Bayer Company Information
13.1.2 Bayer Functional Dyspepsia Drug Product Portfolios and Specifications
13.1.3 Bayer Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Bayer Main Business Overview
13.1.5 Bayer Latest Developments
13.2 Sumitomo
13.2.1 Sumitomo Company Information
13.2.2 Sumitomo Functional Dyspepsia Drug Product Portfolios and Specifications
13.2.3 Sumitomo Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Sumitomo Main Business Overview
13.2.5 Sumitomo Latest Developments
13.3 Cadila Pharmaceuticals
13.3.1 Cadila Pharmaceuticals Company Information
13.3.2 Cadila Pharmaceuticals Functional Dyspepsia Drug Product Portfolios and Specifications
13.3.3 Cadila Pharmaceuticals Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Cadila Pharmaceuticals Main Business Overview
13.3.5 Cadila Pharmaceuticals Latest Developments
13.4 Teva
13.4.1 Teva Company Information
13.4.2 Teva Functional Dyspepsia Drug Product Portfolios and Specifications
13.4.3 Teva Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Teva Main Business Overview
13.4.5 Teva Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Functional Dyspepsia Drug Product Portfolios and Specifications
13.5.3 Johnson & Johnson Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Functional Dyspepsia Drug Product Portfolios and Specifications
13.6.3 Pfizer Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Sanofi
13.7.1 Sanofi Company Information
13.7.2 Sanofi Functional Dyspepsia Drug Product Portfolios and Specifications
13.7.3 Sanofi Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Sanofi Main Business Overview
13.7.5 Sanofi Latest Developments
13.8 AstraZeneca
13.8.1 AstraZeneca Company Information
13.8.2 AstraZeneca Functional Dyspepsia Drug Product Portfolios and Specifications
13.8.3 AstraZeneca Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 AstraZeneca Main Business Overview
13.8.5 AstraZeneca Latest Developments
13.9 Jiangsu Aosaikang Pharma
13.9.1 Jiangsu Aosaikang Pharma Company Information
13.9.2 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Product Portfolios and Specifications
13.9.3 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Jiangsu Aosaikang Pharma Main Business Overview
13.9.5 Jiangsu Aosaikang Pharma Latest Developments
13.10 Eisai
13.10.1 Eisai Company Information
13.10.2 Eisai Functional Dyspepsia Drug Product Portfolios and Specifications
13.10.3 Eisai Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Eisai Main Business Overview
13.10.5 Eisai Latest Developments
13.11 Kyowa Kirin Pharmaceuticals
13.11.1 Kyowa Kirin Pharmaceuticals Company Information
13.11.2 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Product Portfolios and Specifications
13.11.3 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Kyowa Kirin Pharmaceuticals Main Business Overview
13.11.5 Kyowa Kirin Pharmaceuticals Latest Developments
13.12 Hanmi Pharm
13.12.1 Hanmi Pharm Company Information
13.12.2 Hanmi Pharm Functional Dyspepsia Drug Product Portfolios and Specifications
13.12.3 Hanmi Pharm Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Hanmi Pharm Main Business Overview
13.12.5 Hanmi Pharm Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1.Functional Dyspepsia Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2.Functional Dyspepsia Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Prokinetic Drugs
Table 4. Major Players of Gastric Antisecretory Drugs
Table 5. Major Players of Others
Table 6. GlobalFunctional Dyspepsia Drug Sales byType (2020-2025) & (M Units)
Table 7. GlobalFunctional Dyspepsia Drug Sales Market Share byType (2020-2025)
Table 8. GlobalFunctional Dyspepsia Drug Revenue byType (2020-2025) & ($ million)
Table 9. GlobalFunctional Dyspepsia Drug Revenue Market Share byType (2020-2025)
Table 10. GlobalFunctional Dyspepsia Drug Sale Price byType (2020-2025) & (US$/Unit)
Table 11. GlobalFunctional Dyspepsia Drug Sale by Application (2020-2025) & (M Units)
Table 12. GlobalFunctional Dyspepsia Drug Sale Market Share by Application (2020-2025)
Table 13. GlobalFunctional Dyspepsia Drug Revenue by Application (2020-2025) & ($ million)
Table 14. GlobalFunctional Dyspepsia Drug Revenue Market Share by Application (2020-2025)
Table 15. GlobalFunctional Dyspepsia Drug Sale Price by Application (2020-2025) & (US$/Unit)
Table 16. GlobalFunctional Dyspepsia Drug Sales by Company (2020-2025) & (M Units)
Table 17. GlobalFunctional Dyspepsia Drug Sales Market Share by Company (2020-2025)
Table 18. GlobalFunctional Dyspepsia Drug Revenue by Company (2020-2025) & ($ millions)
Table 19. GlobalFunctional Dyspepsia Drug Revenue Market Share by Company (2020-2025)
Table 20. GlobalFunctional Dyspepsia Drug Sale Price by Company (2020-2025) & (US$/Unit)
Table 21. Key ManufacturersFunctional Dyspepsia Drug Producing Area Distribution and Sales Area
Table 22. PlayersFunctional Dyspepsia Drug Products Offered
Table 23.Functional Dyspepsia Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. GlobalFunctional Dyspepsia Drug Sales by Geographic Region (2020-2025) & (M Units)
Table 27. GlobalFunctional Dyspepsia Drug Sales Market Share Geographic Region (2020-2025)
Table 28. GlobalFunctional Dyspepsia Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. GlobalFunctional Dyspepsia Drug Revenue Market Share by Geographic Region (2020-2025)
Table 30. GlobalFunctional Dyspepsia Drug Sales by Country/Region (2020-2025) & (M Units)
Table 31. GlobalFunctional Dyspepsia Drug Sales Market Share by Country/Region (2020-2025)
Table 32. GlobalFunctional Dyspepsia Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. GlobalFunctional Dyspepsia Drug Revenue Market Share by Country/Region (2020-2025)
Table 34. AmericasFunctional Dyspepsia Drug Sales by Country (2020-2025) & (M Units)
Table 35. AmericasFunctional Dyspepsia Drug Sales Market Share by Country (2020-2025)
Table 36. AmericasFunctional Dyspepsia Drug Revenue by Country (2020-2025) & ($ millions)
Table 37. AmericasFunctional Dyspepsia Drug Sales byType (2020-2025) & (M Units)
Table 38. AmericasFunctional Dyspepsia Drug Sales by Application (2020-2025) & (M Units)
Table 39. APACFunctional Dyspepsia Drug Sales by Region (2020-2025) & (M Units)
Table 40. APACFunctional Dyspepsia Drug Sales Market Share by Region (2020-2025)
Table 41. APACFunctional Dyspepsia Drug Revenue by Region (2020-2025) & ($ millions)
Table 42. APACFunctional Dyspepsia Drug Sales byType (2020-2025) & (M Units)
Table 43. APACFunctional Dyspepsia Drug Sales by Application (2020-2025) & (M Units)
Table 44. EuropeFunctional Dyspepsia Drug Sales by Country (2020-2025) & (M Units)
Table 45. EuropeFunctional Dyspepsia Drug Revenue by Country (2020-2025) & ($ millions)
Table 46. EuropeFunctional Dyspepsia Drug Sales byType (2020-2025) & (M Units)
Table 47. EuropeFunctional Dyspepsia Drug Sales by Application (2020-2025) & (M Units)
Table 48. Middle East & AfricaFunctional Dyspepsia Drug Sales by Country (2020-2025) & (M Units)
Table 49. Middle East & AfricaFunctional Dyspepsia Drug Revenue Market Share by Country (2020-2025)
Table 50. Middle East & AfricaFunctional Dyspepsia Drug Sales byType (2020-2025) & (M Units)
Table 51. Middle East & AfricaFunctional Dyspepsia Drug Sales by Application (2020-2025) & (M Units)
Table 52. Key Market Drivers & Growth Opportunities ofFunctional Dyspepsia Drug
Table 53. Key Market Challenges & Risks ofFunctional Dyspepsia Drug
Table 54. Key IndustryTrends ofFunctional Dyspepsia Drug
Table 55.Functional Dyspepsia Drug Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57.Functional Dyspepsia Drug Distributors List
Table 58.Functional Dyspepsia Drug Customer List
Table 59. GlobalFunctional Dyspepsia Drug SalesForecast by Region (2026-2031) & (M Units)
Table 60. GlobalFunctional Dyspepsia Drug RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. AmericasFunctional Dyspepsia Drug SalesForecast by Country (2026-2031) & (M Units)
Table 62. AmericasFunctional Dyspepsia Drug Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APACFunctional Dyspepsia Drug SalesForecast by Region (2026-2031) & (M Units)
Table 64. APACFunctional Dyspepsia Drug Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. EuropeFunctional Dyspepsia Drug SalesForecast by Country (2026-2031) & (M Units)
Table 66. EuropeFunctional Dyspepsia Drug RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & AfricaFunctional Dyspepsia Drug SalesForecast by Country (2026-2031) & (M Units)
Table 68. Middle East & AfricaFunctional Dyspepsia Drug RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. GlobalFunctional Dyspepsia Drug SalesForecast byType (2026-2031) & (M Units)
Table 70. GlobalFunctional Dyspepsia Drug RevenueForecast byType (2026-2031) & ($ millions)
Table 71. GlobalFunctional Dyspepsia Drug SalesForecast by Application (2026-2031) & (M Units)
Table 72. GlobalFunctional Dyspepsia Drug RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Bayer Basic Information,Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 74. BayerFunctional Dyspepsia Drug Product Portfolios and Specifications
Table 75. BayerFunctional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 76. Bayer Main Business
Table 77. Bayer Latest Developments
Table 78. Sumitomo Basic Information,Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 79. SumitomoFunctional Dyspepsia Drug Product Portfolios and Specifications
Table 80. SumitomoFunctional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Sumitomo Main Business
Table 82. Sumitomo Latest Developments
Table 83. Cadila Pharmaceuticals Basic Information,Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 84. Cadila PharmaceuticalsFunctional Dyspepsia Drug Product Portfolios and Specifications
Table 85. Cadila PharmaceuticalsFunctional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 86. Cadila Pharmaceuticals Main Business
Table 87. Cadila Pharmaceuticals Latest Developments
Table 88.Teva Basic Information,Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 89.TevaFunctional Dyspepsia Drug Product Portfolios and Specifications
Table 90.TevaFunctional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 91.Teva Main Business
Table 92.Teva Latest Developments
Table 93. Johnson & Johnson Basic Information,Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. Johnson & JohnsonFunctional Dyspepsia Drug Product Portfolios and Specifications
Table 95. Johnson & JohnsonFunctional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. Johnson & Johnson Main Business
Table 97. Johnson & Johnson Latest Developments
Table 98. Pfizer Basic Information,Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. PfizerFunctional Dyspepsia Drug Product Portfolios and Specifications
Table 100. PfizerFunctional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 101. Pfizer Main Business
Table 102. Pfizer Latest Developments
Table 103. Sanofi Basic Information,Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. SanofiFunctional Dyspepsia Drug Product Portfolios and Specifications
Table 105. SanofiFunctional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 106. Sanofi Main Business
Table 107. Sanofi Latest Developments
Table 108. AstraZeneca Basic Information,Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. AstraZenecaFunctional Dyspepsia Drug Product Portfolios and Specifications
Table 110. AstraZenecaFunctional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 111. AstraZeneca Main Business
Table 112. AstraZeneca Latest Developments
Table 113. Jiangsu Aosaikang Pharma Basic Information,Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 114. Jiangsu Aosaikang PharmaFunctional Dyspepsia Drug Product Portfolios and Specifications
Table 115. Jiangsu Aosaikang PharmaFunctional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 116. Jiangsu Aosaikang Pharma Main Business
Table 117. Jiangsu Aosaikang Pharma Latest Developments
Table 118. Eisai Basic Information,Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 119. EisaiFunctional Dyspepsia Drug Product Portfolios and Specifications
Table 120. EisaiFunctional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 121. Eisai Main Business
Table 122. Eisai Latest Developments
Table 123. Kyowa Kirin Pharmaceuticals Basic Information,Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 124. Kyowa Kirin PharmaceuticalsFunctional Dyspepsia Drug Product Portfolios and Specifications
Table 125. Kyowa Kirin PharmaceuticalsFunctional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 126. Kyowa Kirin Pharmaceuticals Main Business
Table 127. Kyowa Kirin Pharmaceuticals Latest Developments
Table 128. Hanmi Pharm Basic Information,Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 129. Hanmi PharmFunctional Dyspepsia Drug Product Portfolios and Specifications
Table 130. Hanmi PharmFunctional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 131. Hanmi Pharm Main Business
Table 132. Hanmi Pharm Latest Developments
LIST OFFIGURES
Figure 1. Picture ofFunctional Dyspepsia Drug
Figure 2.Functional Dyspepsia Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. GlobalFunctional Dyspepsia Drug Sales Growth Rate 2020-2031 (M Units)
Figure 7. GlobalFunctional Dyspepsia Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8.Functional Dyspepsia Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9.Functional Dyspepsia Drug Sales Market Share by Country/Region (2024)
Figure 10.Functional Dyspepsia Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Prokinetic Drugs
Figure 12. Product Picture of Gastric Antisecretory Drugs
Figure 13. Product Picture of Others
Figure 14. GlobalFunctional Dyspepsia Drug Sales Market Share byType in 2025
Figure 15. GlobalFunctional Dyspepsia Drug Revenue Market Share byType (2020-2025)
Figure 16.Functional Dyspepsia Drug Consumed in Hospitals
Figure 17. GlobalFunctional Dyspepsia Drug Market: Hospitals (2020-2025) & (M Units)
Figure 18.Functional Dyspepsia Drug Consumed in Drugstores
Figure 19. GlobalFunctional Dyspepsia Drug Market: Drugstores (2020-2025) & (M Units)
Figure 20. GlobalFunctional Dyspepsia Drug Sale Market Share by Application (2024)
Figure 21. GlobalFunctional Dyspepsia Drug Revenue Market Share by Application in 2025
Figure 22.Functional Dyspepsia Drug Sales by Company in 2025 (M Units)
Figure 23. GlobalFunctional Dyspepsia Drug Sales Market Share by Company in 2025
Figure 24.Functional Dyspepsia Drug Revenue by Company in 2025 ($ millions)
Figure 25. GlobalFunctional Dyspepsia Drug Revenue Market Share by Company in 2025
Figure 26. GlobalFunctional Dyspepsia Drug Sales Market Share by Geographic Region (2020-2025)
Figure 27. GlobalFunctional Dyspepsia Drug Revenue Market Share by Geographic Region in 2025
Figure 28. AmericasFunctional Dyspepsia Drug Sales 2020-2025 (M Units)
Figure 29. AmericasFunctional Dyspepsia Drug Revenue 2020-2025 ($ millions)
Figure 30. APACFunctional Dyspepsia Drug Sales 2020-2025 (M Units)
Figure 31. APACFunctional Dyspepsia Drug Revenue 2020-2025 ($ millions)
Figure 32. EuropeFunctional Dyspepsia Drug Sales 2020-2025 (M Units)
Figure 33. EuropeFunctional Dyspepsia Drug Revenue 2020-2025 ($ millions)
Figure 34. Middle East & AfricaFunctional Dyspepsia Drug Sales 2020-2025 (M Units)
Figure 35. Middle East & AfricaFunctional Dyspepsia Drug Revenue 2020-2025 ($ millions)
Figure 36. AmericasFunctional Dyspepsia Drug Sales Market Share by Country in 2025
Figure 37. AmericasFunctional Dyspepsia Drug Revenue Market Share by Country (2020-2025)
Figure 38. AmericasFunctional Dyspepsia Drug Sales Market Share byType (2020-2025)
Figure 39. AmericasFunctional Dyspepsia Drug Sales Market Share by Application (2020-2025)
Figure 40. United StatesFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 41. CanadaFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 42. MexicoFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 43. BrazilFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 44. APACFunctional Dyspepsia Drug Sales Market Share by Region in 2025
Figure 45. APACFunctional Dyspepsia Drug Revenue Market Share by Region (2020-2025)
Figure 46. APACFunctional Dyspepsia Drug Sales Market Share byType (2020-2025)
Figure 47. APACFunctional Dyspepsia Drug Sales Market Share by Application (2020-2025)
Figure 48. ChinaFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 49. JapanFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 50. South KoreaFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 51. Southeast AsiaFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 52. IndiaFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 53. AustraliaFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 54. ChinaTaiwanFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. EuropeFunctional Dyspepsia Drug Sales Market Share by Country in 2025
Figure 56. EuropeFunctional Dyspepsia Drug Revenue Market Share by Country (2020-2025)
Figure 57. EuropeFunctional Dyspepsia Drug Sales Market Share byType (2020-2025)
Figure 58. EuropeFunctional Dyspepsia Drug Sales Market Share by Application (2020-2025)
Figure 59. GermanyFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 60.FranceFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 61. UKFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 62. ItalyFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 63. RussiaFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 64. Middle East & AfricaFunctional Dyspepsia Drug Sales Market Share by Country (2020-2025)
Figure 65. Middle East & AfricaFunctional Dyspepsia Drug Sales Market Share byType (2020-2025)
Figure 66. Middle East & AfricaFunctional Dyspepsia Drug Sales Market Share by Application (2020-2025)
Figure 67. EgyptFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 68. South AfricaFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 69. IsraelFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 70.TurkeyFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 71. GCC CountriesFunctional Dyspepsia Drug Revenue Growth 2020-2025 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis ofFunctional Dyspepsia Drug in 2025
Figure 73. Manufacturing Process Analysis ofFunctional Dyspepsia Drug
Figure 74. Industry Chain Structure ofFunctional Dyspepsia Drug
Figure 75. Channels of Distribution
Figure 76. GlobalFunctional Dyspepsia Drug Sales MarketForecast by Region (2026-2031)
Figure 77. GlobalFunctional Dyspepsia Drug Revenue Market ShareForecast by Region (2026-2031)
Figure 78. GlobalFunctional Dyspepsia Drug Sales Market ShareForecast byType (2026-2031)
Figure 79. GlobalFunctional Dyspepsia Drug Revenue Market ShareForecast byType (2026-2031)
Figure 80. GlobalFunctional Dyspepsia Drug Sales Market ShareForecast by Application (2026-2031)
Figure 81. GlobalFunctional Dyspepsia Drug Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Cough Expectorant Market Growth 2023-2029
US$ 3,660.00
February 2023
97 pages
Global Radiopharmaceuticals Market Growth 2024-2030
US$ 3,660.00
January 2024
138 pages
Global Digital Biomarker Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
April 2025
121 pages
Global Infrared Vein Finder Market Growth 2024-2030
US$ 3,660.00
June 2024
119 pages
